The Journal of Allergy and Clinical Immunology
Volume 121, Issue 4 , Pages 839-844 , April 2008

Advances in the care of adults with asthma and allergy in 2007

  • Andrea J. Apter, MD, MSc

      Affiliations

    • Corresponding Author InformationReprint requests: Andrea J. Apter, MD, MSc, 829 Gates Building, Hospital of the University of Pennsylvania, 3600 Spruce Street, Philadelphia, PA 19104.

Received 20 December 2007 ,Revised 27 December 2007 ,Accepted 27 December 2007.

References 

  1. Apter AJ, Szefler SJ. Advances in adult and pediatric asthma. J Allergy Clin Immunol. 2006;117:512–518
  2. Apter AJ, Szefler SJ. Advances in adult and pediatric asthma. J Allergy Clin Immunol. 2004;113:407–414
  3. Szefler SJ, Apter A. Advances in pediatric and adult asthma. J Allergy Clin Immunol. 2005;115:470–477
  4. Apter AJ. Advances in adult asthma 2006: its risk factors, course, and management. J Allergy Clin Immunol. 2007;119:563–566
  5. Busse WW. National Asthma Education and Prevention Program Report 3: guidelines for the diagnosis and management of asthma, summary report 2007. J Allergy Clin Immunol. 2007;120:S1–S138
  6. National Institutes of Health . National Heart, Lung, and Blood Institute. National Asthma Education and Prevention Program. Expert Panel Report 3: guidelines for the diagnosis and management of asthma. Washington (DC): NIH; 2007;NIH publication no. 07-4051
  7. Burgess JA, Walters EH, Byrnes GB, Matheson MC, Jenkins MA, Wharton CL, et al. Childhood allergic rhinitis predicts asthma incidence and persistence to middle age: a longitudinal study. J Allergy Clin Immunol. 2007;120:863–869
  8. Arbes SJ, Gergen PJ, Baughn B, Zeldin DC. Asthma cases attributable to atopy: results from the third National Health and Nutrition Examination Survey. J Allergy Clin Immunol. 2007;120:1139–1145
  9. Litonjua AA, Celedon JC, Hausmann J, Nikolov M, Sredl D, Ryan L, et al. Variation in total and specific IgE: effects of ethnicity and socioeconomic status. J Allergy Clin Immunol. 2005;115:751–757
  10. Naqvi M, Choudhry S, Tsai HJ, Thyne S, Navarro D, Nazario S, et al. Association between IgE levels and asthma severity among African American, Mexican, and Puerto Rican patients with asthma. J Allergy Clin Immunol. 2007;120:137–143
  11. Ownby DR, Joseph CL. Should non-atopic asthma get equal attention?. J Allergy Clin Immunol. 2007;120:1018–1020
  12. Real FG, Svanes C, Omenaas ER, Antò JM, Plana E, Jarvis D, et al. Lung function, respiratory symptoms, and the menopausal transition. J Allergy Clin Immunol. 2007;Oct 26 [epub ahead of print]
  13. Rowe J, Kusel M, Holt BJ, Suriyaarachchi D, Serralha M, Hollams E, et al. Prenatal versus postnatal sensitization to environmental allergens in a high-risk birth cohort. J Allergy Clin Immunol. 2007;119:1164–1173
  14. Celedon JC, Milton DK, Ramsey CD, Litonjua AA, Ryan L, Platts-Mills TA, et al. Exposure to dust mite allergen and endotoxin in early life and asthma and atopy in childhood. J Allergy Clin Immunol. 2007;120:144–149
  15. Kattan M, Gergen PJ, Eggleston P, Visness CM, Mitchell HE. Health effects of indoor nitrogen dioxide and passive smoking on urban asthmatic children. J Allergy Clin Immunol. 2007;120:618–624
  16. Wisnivesky JP, Sampson H, Berns S, Kattan M, Halm EA. Lack of association between indoor allergen sensitization and asthma morbidity in inner-city adults. J Allergy Clin Immunol. 2007;120:113–120
  17. Mosnaim GS, Sadowski LS, Durazo-Arvizu RA, Sharp LK, Curtis LM, Shalowitz MU, et al. Parental language and asthma among urban Hispanic children. J Allergy Clin Immunol. 2007;120:1160–1165
  18. Kuiper S, Muris JW, Dompeling E, Kester AD, Wesseling G, Knottnerus JA, et al. Interactive effect of family history and environmental factors on respiratory tract-related morbidity in infancy. J Allergy Clin Immunol. 2007;120:388–395
  19. Rand C, Bilderback A, Schiller K, Edelman JM, Hustad CM, Zeiger RS. Adherence with montelukast or fluticasone in a long-term clinical trial: results from the Mild Asthma Montelukast Versus Inhaled Corticosteroid Trial. J Allergy Clin Immunol. 2007;119:916–923
  20. Williams LK, Joseph CL, Peterson EL, Moon C, Xi H, Krajenta R, et al. Race-ethnicity, crime, and other factors associated with adherence to inhaled corticosteroids. J Allergy Clin Immunol. 2007;119:168–175
  21. Gergen PJ, Apter AJ. Unconventional risk factors: another pathway to understanding health disparities. J Allergy Clin Immunol. 2007;119:165–167
  22. Baptist AP, Warrier I, Arora R, Ager J, Massanari RM. Hospitalized patients with asthma who leave against medical advice: characteristics, reasons, and outcomes. J Allergy Clin Immunology. 2007;119:924–929
  23. Enriquez R, Griffin MR, Carroll KN, Wu P, Cooper WO, Gebretsadik T, et al. Effect of maternal asthma and asthma control on pregnancy and perinatal outcomes. J Allergy Clin Immunol. 2007;120:625–630
  24. Basheti IA, Reddel HK, Armour CL, Bosnic-Anticevich SZ. Improved asthma outcomes with a simple inhaler technique intervention by community pharmacists. J Allergy Clin Immunol. 2007;119:1537–1538
  25. Jones CA, Clement LT, Morphew T, Kwong KY, Hanley-Lopez J, Lifson F, et al. Achieving and maintaining asthma control in an urban pediatric disease management program: the Breathmobile Program. J Allergy Clin Immunol. 2007;119:1445–1453
  26. Borrelli B, Riekert KA, Weinstein A, Cardella L. Brief motivational interviewing as a clinical strategy to promote asthma medication adherence. J Allergy Clin Immunol. 2007;120:1023–1030
  27. Chen H, Gould MK, Blanc PD, Miller DP, Kamath TV, Lee JH, et al. Asthma control, severity, and quality of life: quantifying the effect of uncontrolled disease. J Allergy Clin Immunol. 2007;120:396–402
  28. Schatz M, Zeiger RS, Drane A, Harden K, Cibildak A, Oosterman JE, et al. Reliability and predictive validity of the Asthma Control Test administered by telephone calls using speech recognition technology. J Allergy Clin Immunol. 2007;119:336–343
  29. Liu AH, Zeiger R, Sorkness C, Mahr T, Ostrom N, Burgess S, et al. Development and cross-sectional validation of the Childhood Asthma Control Test. J Allergy Clin Immunol. 2007;119:817–825
  30. Wood PR, Smith B, O'Donnell L, Galbreath AD, Lara M, Forkner E, et al. Quantifying asthma symptoms in adults: the Asthma Symptom Scale. J Allergy Clin Immunol. 2007;120:1368–1372
  31. Yoo K, Johnson SK, Voigt RG, Campeau LJ, Yawn BP, Juhn YJ. Characterization of asthma status by parent report and medical record review. J Allergy Clin Immunol. 2007;120:1468–1469
  32. Apter AJ. Reply. J Allergy Clin Immunol. 2007;120:729
  33. Wu AC, Paltiel D, Kuntz KM, Weiss ST, Fuhlbrigge AL. Cost-effectiveness of omalizumab in adults with severe asthma: results from the Asthma Policy Model. J Allergy Clin Immunol. 2007;120:1146–1152
  34. Krishnan JA, Gould M. Omalizumab for severe allergic asthma: dollars and sense. J Allergy Clin Immunol. 2007;120:1015–1017
  35. Omalizumab (for subcutaneous use) (marketed as Xolair). 2007. Bethesda (MD): US Food and Drug Administration. Available at: http://www.fda.gov/cder/drug/InfoSheets/HCP/omalizumabHCP.pdf. Accessed December 26, 2007.
  36. Limb SL, Starke PR, Lee CE, Chowdhury BA. Delayed onset and protracted progression of anaphylaxis after omalizumab administration in patients with asthma. J Allergy Clin Immunol. 2007;120:1378–1381
  37. Menzies D, Nair A, Meldrum KT, Fleming D, Barnes M, Lipworth BJ. Simvastatin does not exhibit therapeutic anti-inflammatory effects in asthma. J Allergy Clin Immunol. 2007;119:328–335
  38. ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. Am J Respir Crit Care Med. 2005;171:912–930
  39. de Marco R, Marcon A, Jarvis D, Accordini S, Bugiani M, Cazzoletti L, et al. Inhaled steroids are associated with reduced lung function decline in subjects with asthma with elevated total IgE. J Allergy Clin Immunol. 2007;119:611–617
  40. Chipps BE, Szefler SJ, Simons FE, Haselkorn T, Mink DR, Deniz Y, et al. Demographic and clinical characteristics of children and adolescents with severe or difficult-to-treat asthma. J Allergy Clin Immunol. 2007;119:1156–1163
  41. Dolan CM, Fraher KE, Bleecker ER, Borish L, Chipps B, Hayden ML, et al. Design and baseline characteristics of the epidemiology and natural history of asthma: Outcomes and Treatment Regimens (TENOR) study: a large cohort of patients with severe or difficult-to-treat asthma. Ann Allergy Asthma Immunol. 2004;92:32–39
  42. Nelson HS, Weiss ST, Bleecker ER, Yancey SW, Dorinsky PM. The Salmeterol Multicenter Asthma Research Trial: a comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol. Chest. 2006;129:15–26
  43. Salpeter SR, Buckley NS, Ormiston TM, Salpeter EE. Meta-analysis: effect of long-acting beta-agonists on severe asthma exacerbations and asthma-related deaths. Ann Intern Med. 2006;144:904–912
  44. Szefler SJ, Whelan GJ, Leung DY. “Black box” warning: wake-up call or overreaction?. J Allergy Clin Immunol. 2006;117:26–29
  45. Chinchilli VM. General principles for systematic reviews and meta-analyses and a critique of a recent systematic review of long-acting beta-agonists. J Allergy Clin Immunol. 2007;119:303–306
  46. Camargo CA, Clark S, Kaplan MS, Lieberman P, Wood RA. Regional differences in EpiPen prescriptions in the United States: the potential role of vitamin D. J Allergy Clin Immunol. 2007;120:131–136
  47. Taback SP, Simons FE. Anaphylaxis and vitamin D: a role for the sunshine hormone?. J Allergy Clin Immunol. 2007;120:128–130
  48. Kemeny ME, Rosenwasser LJ, Panettieri RA, Rose RM, Berg-Smith SM, Kline JN. Placebo response in asthma: a robust and objective phenomenon. J Allergy Clin Immunol. 2007;119:1375–1381
  49. Tunon-de-Lara JM, Laurent F, Giraud V, Perez T, Aguilaniu B, Meziane H, et al. Air trapping in mild and moderate asthma: effect of inhaled corticosteroids. J Allergy Clin Immunol. 2007;119:583–590
  50. Dragonieri S, Schot R, Mertens BJ, Le Cessie S, Gauw SA, Spanevello A, et al. An electronic nose in the discrimination of patients with asthma and controls. J Allergy Clin Immunol. 2007;120:856–862
  51. Bourdin A, Neveu D, Vachier I, Paganin F, Godard P, Chanez P. Specificity of basement membrane thickening in severe asthma. J Allergy Clin Immunol. 2007;119:1367–1374
  52. de Lange EE, Altes TA, Patrie JT, Parmar J, Brookeman JR, Mugler JP, et al. The variability of regional airflow obstruction within the lungs of patients with asthma: assessment with hyperpolarized helium-3 magnetic resonance imaging. J Allergy Clin Immunol. 2007;119:1072–1078
  53. Simons FE. Eventual full-text publication of research abstracts presented at an allergy/immunology meeting. J Allergy Clin Immunol. 2007;119:499–501
  54. Austen KF. The National Institute of Allergy and Infectious Diseases' Asthma and Allergic Disease Centers: a personal commentary. J Allergy Clin Immunol. 2007;119:34–35

 Supported by R01 HL073932 and K02 HL088469.

 Disclosure of potential conflict of interest: A. J. Apter has received research support from the National Heart, Lung, and Blood Institute.

PII: S0091-6749(08)00006-7

doi: 10.1016/j.jaci.2007.12.1176

The Journal of Allergy and Clinical Immunology
Volume 121, Issue 4 , Pages 839-844 , April 2008

Article Tools

* Image Usage & Resolution